BFA
GNMK

BlackRock Fund Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

BlackRock Fund Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$18.3M Buy
1,493,076
+382,528
+34% +$4.54M ﹤0.01% 2232
2016
Q3 		$13.1M Buy
1,110,548
+62,964
+6% +$608K ﹤0.01% 2314
2016
Q2 		$9.11M Sell
1,047,584
-46,344
-4% -$318K ﹤0.01% 2455
2016
Q1 		$5.76M Sell
1,093,928
-201,972
-16% -$1.12M ﹤0.01% 2668
2015
Q4 		$10.1M Buy
1,295,900
+59,065
+5% +$454K ﹤0.01% 2445
2015
Q3 		$9.73M Sell
1,236,835
-74,366
-6% -$688K ﹤0.01% 2383
2015
Q2 		$11.9M Sell
1,311,201
-12,316
-0.9% -$124K ﹤0.01% 2409
2015
Q1 		$17.2M Buy
1,323,517
+163,996
+14% +$2.14M ﹤0.01% 2145
2014
Q4 		$15.8M Buy
1,159,521
+151,704
+15% +$1.7M ﹤0.01% 2193
2014
Q3 		$9.04M Sell
1,007,817
-25,708
-2% -$277K ﹤0.01% 2406
2014
Q2 		$14M Buy
1,033,525
+24,460
+2% +$255K ﹤0.01% 2213
2014
Q1 		$10M Buy
1,009,065
+35,159
+4% +$437K ﹤0.01% 2395
2013
Q4 		$12.9M Sell
973,906
-40,843
-4% -$496K ﹤0.01% 2227
2013
Q3 		$12.3M Buy
1,014,749
+284,048
+39% +$3.04M ﹤0.01% 2228
2013
Q2 		$7.56M Buy
+730,701
New +$10.1M ﹤0.01% 2439

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors's GNMK Position: Q4 2016 in Review

BlackRock Fund Advisors increased its GenMark Diagnostics, Inc (GNMK) stake by 34% in Q4 2016, buying an estimated $4.54M and bringing the position to 1,493,076 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

BlackRock Fund Advisors first reported a position in GNMK in Q2 2013 and has held it in 15 quarters since. 90 funds tracked by Wall St. Rank hold GNMK as of Q4 2016.

  • BlackRock Fund Advisors held 1,493,076 shares of GenMark Diagnostics, Inc worth $18.3M as of Q4 2016.
  • BlackRock Fund Advisors bought 382,528 GenMark Diagnostics, Inc shares in Q4 2016, an estimated $4.54M.
  • GenMark Diagnostics, Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2232 holding.
  • BlackRock Fund Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and has held it in 15 quarters since.
  • 90 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.